Orchard Therapeutics
Clinical trials sponsored by Orchard Therapeutics, explained in plain language.
-
Gene therapy trial offers hope for cure of devastating childhood disease
⭐️ CURE ⭐️ OngoingThis study is testing whether a new gene therapy called OTL-203 works better and is safer than the current standard treatment (stem cell transplant) for children with Hurler syndrome. Hurler syndrome is a severe genetic disorder that causes progressive damage to the brain, bones,…
Phase: PHASE3 • Sponsor: Orchard Therapeutics • Aim: ⭐️ CURE ⭐️
Last updated Mar 30, 2026 14:28 UTC
-
One-Time gene therapy tested to halt devastating childhood brain disease
Disease control OngoingThis study is testing a single infusion of an experimental gene therapy called OTL-200 in up to 6 children with late juvenile metachromatic leukodystrophy (MLD), a rare and severe genetic brain disease. The therapy aims to correct the underlying genetic cause by giving the patien…
Phase: PHASE3 • Sponsor: Orchard Therapeutics • Aim: Disease control
Last updated Apr 02, 2026 05:41 UTC
-
One-Time treatment aims to halt devastating childhood disease
Disease control OngoingThis study is testing a one-time gene therapy for children with Hurler syndrome, a severe and life-limiting genetic disorder. Doctors collect a child's own blood stem cells, add a corrected gene in the lab, and then return the cells to the child. The main goals are to see if this…
Phase: PHASE1, PHASE2 • Sponsor: Orchard Therapeutics • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC